PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 2391 (114th)

Medicaid Generic Drug Price Fairness Act of 2015

referredUnited States· United States Congress· EN

Introduced

18 May 2015

Last action

22 May 2015 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

ELIJAH CUMMINGS, Del. Norton, Eleanor Holmes [D-DC-At Large], SANDER LEVIN, John Sarbanes, Rep. Edwards, Donna F. [D-MD-4], Rep. Brown, Corrine [D-FL-5], Rep. DeSaulnier, Mark [D-CA-10], Marcia Fudge, ALCEE HASTINGS, Matt Cartwright, Michelle Lujan Grisham

Subjects

Healthcare

Source updated

5 December 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Medicaid Generic Drug Price Fairness Act of 2015 This bill amends title XIX (Medicaid) of the Social Security Act to increase the amount of rebate with respect to each generic drug in the manner that the rebate for a dosage form and strength of a single source drug or an innovator multiple source drug is increased, except as provided in special application rules, including a special rule for certain noninnovator multiple source drugs.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 18 May 2015

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 18 May 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 18 May 2015

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 22 May 2015

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.